ALPHACENTRIC ADVISORS LLC – Revance Therapeutics, Inc. Transaction History
ALPHACENTRIC ADVISORS LLC portfolio value:
$0
portfolio value
ALPHACENTRIC ADVISORS LLC quarter portfolio value change:
+63.74%
quarter
Revance Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -65K shares | -1.06M | $27 | 0 |
| Q4 2021 | share | Increase | +900.00% | 58.5K shares | 880K | $16.49 | 65K |
| Q3 2021 | share | 0.00% | 0 shares | -12K | $27.86 | 6.5K | |
| Q2 2021 | share | 0.00% | 0 shares | 11K | $29.64 | 6.5K | |
| Q1 2021 | share | Increase | +160.00% | 4K shares | 111K | $27.95 | 6.5K |
| Q4 2020 | share | Increase | 0.00% | 2.5K shares | 71K | $28.34 | 2.5K |